Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smoking Cessation Claims For E-Cigarettes Draw FDA Warnings

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA is in discussions with multiple firms about new drug applications for electronic cigarettes as it warns five firms that smoking cessation claims make their e-cigarettes unapproved new drugs.

You may also be interested in...



FDA appeals e-cigarette ruling

FDA Feb. 1 appeals the U.S. District Court for the District of Columbia's decision in January that electronic cigarettes are tobacco products despite the agency's interpretation the products are unapproved drug devices. FDA in July warned consumers about e-cigarettes and stopped shipments from entering the U.S. because tested lots contained toxic materials (1"The Tan Sheet" Jan. 18, 2010, In Brief). In the agency's motion to appeal the Jan. 14 decision, FDA asks the court for "an immediate temporary stay to permit consideration of this stay motion," explaining that the Family Smoking Prevention and Tobacco Control Act excludes under the "tobacco products" definition any item that is a drug, device or combination product under the Food, Drug and Cosmetic Act

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade

Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel